About:
Ensoma is developing in vivo treatments for immuno-oncology. With their name derived from the Greek phrase “en soma”, meaning in the body, Ensoma’s approach is built on the view that the future of medicine lies within us. To develop therapies, Ensoma is using their EngeniousTM platform that combines delivery technology with the full DNA editing toolkit within a single platform. Ensoma is targeting the hematopoietic system since it is the source of blood and immune cells for the body and is linked with health and disease. Through in vivo editing of the immune system, Ensoma can engineer the body’s natural defenses to overcome the immuno-suppressive abilities of tumors and can engineer multiple cell types simultaneously offering an innovative way to treat cancer.
Jobs:
Analytical Scientist, Analytical Development Boston, MA|7 days ago
Associate Director, Gene Editing (Protein Design) Boston, MA|20 days ago